Thatch, a platform that reduces healthcare expenses for companies while broadening insurance options for their workers, has secured $108 million in fresh funding at a $1 billion valuation, according to TechCrunch reporting published September 15, 2026. The financing round was led by existing backers including The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz. The milestone represents an unusually steep climb for a startup that doesn't position itself primarily as an artificial intelligence company.

The funding arrives 17 months after Thatch raised $40 million in a Series B round valued at $410 million, according to PitchBook data cited in the report. That translates to more than a doubling of the company's valuation in less than a year and a half. During the same period, co-founder and CEO Chris Ellis told TechCrunch that the company expanded its annual recurring revenue roughly sevenfold. Ellis launched Thatch in 2021 alongside Adam Stevenson, a former engineering executive at Stripe.

Two major industry shifts are fueling the startup's expansion, according to Ellis. First, employer healthcare expenses continue their upward march, with projections showing 2027 costs will climb more than 8% — the steepest jump in over two decades. Second, workers are increasingly seeking access to newer therapies such as GLP-1 medications for weight loss and diabetes management, including drugs like Ozempic and Wegovy, which conventional health plans seldom include in their coverage. Thatch operates by helping companies deploy an Individual Coverage Health Reimbursement Arrangement, or ICHRA — a framework established by federal regulation in 2020 that allows employers to fund workers' individual insurance policies rather than enrolling everyone in a single company-wide plan. Under this model, which recently rebranded as CHOICE, companies no longer negotiate traditional healthcare contracts with individual carriers such as Anthem or United Healthcare. Instead, businesses allocate a set health budget for each employee, who can then apply those pre-tax dollars to select from dozens of health, dental, and vision plans available on Thatch's marketplace. The platform uses artificial intelligence to suggest the best-fit health plan for each worker's particular circumstances. Employees requiring more extensive medical care can add their own money to access more comprehensive coverage, while those in better health can choose less expensive plans and direct the remaining allowance via a Thatch debit card toward other qualifying health costs like GLP-1 drugs or an Oura Ring.

Ellis frames the arrangement as mutually beneficial for both employers and their workforce. "If [employees] don't like their insurance, they can switch to another one," he said in the report. "It creates pressure on insurers to compete for better service, denying fewer claims because they want to keep you as a customer." For employers, the advantage lies in avoiding annual renegotiations with carriers while still delivering equivalent coverage levels, often at marginally reduced expense, he noted. Thatch isn't alone in capitalizing on the six-year-old regulation to present employers with an alternative to traditional health benefits structures. Rivals in this space include startups such as Take Command, Remodel Health, and Zorro. "People are waking up to this because of costs, but then they're realizing this is a better, more efficient way to do it," Ellis said.

The report indicates that rising healthcare costs and demand for modern treatments are converging to accelerate adoption of individual coverage models that give workers greater control over their insurance choices. As traditional group plans struggle to contain expenses and incorporate newer therapies, companies may increasingly turn to platforms that decouple employer funding from carrier selection, allowing each worker to optimize their own coverage. The ICHRA framework positions Thatch and its competitors to capture a larger share of the employer benefits market as awareness of the model grows. For business leaders evaluating benefits strategies, the choice between maintaining centralized group plans and embracing individualized marketplaces will likely hinge on whether flexibility and cost containment outweigh the administrative simplicity of a single carrier relationship. Meanwhile, the success of non-AI-centric startups in commanding billion-dollar valuations may prompt investors to recalibrate their assumptions about which business models can deliver explosive growth in the current environment.